Marinus Pharmaceuticals reported $37.68M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
ALKERMES ALKS:US $ 452.98M 69.54M
Amgen AMGN:US $ 14842M 257M
Aptinyx Inc APTX:US $ 6.28M 2.9M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Biogen BIIB:US $ 4211.6M 864.4M
Eisai 4523:JP Y 280829M 2895M
Enanta Pharmaceuticals ENTA:US $ 36.17M 7.55M
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
Gilead Sciences GILD:US $ 10245M 31M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
Marinus Pharmaceuticals MRNS:US $ 37.68M 20.98M
Minerva Neurosciences NERV:US $ 3.08M 1.36M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Supernus Pharmaceuticals SUPN:US $ 234.71M 48.74M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
YTE INCY:US $ 742.71M 82.39M
Zogenix ZGNX:US $ 78.43M 9.09M